Health Care
Biotech and Pharmaceuticals
featured
Drug companies contributed to the opioid crisis, but so did lots of other stakeholders, says Glenn W. Simon in National Review. » Read More
By: Dan Mangan
Martin Shkreli's bail was revoked last week by a judge for having offered Facebook followers $5,000 for samples of Hillary Clinton's hair. » Read More |
Lior Dayan, CEO of Sisram Medical, says choosing Hong Kong was a natural choice for the company given its presence in China and explains how IPO funds will be used. » Read More |
More
Opioid drugs are generally cheap while safer alternatives are often more expensive, ProPublica reports.
Shkreli, 34, will stay in the Metropolitan Detention Center until he is sentenced Jan. 16 for several securities fraud convictions.
Halozyme CEO Dr. Helen Torley speaks with CNBC's Meg Tirrell about the company using technology that makes it easier for patients to take medicine.
Martin Shkreli was jailed by a judge angry about his offer of $5,000 to Facebook followers to collect samples of Hillary Clinton's hair.
At least 30-percent of depressed patients don't respond to any of the current drugs on the market. Scientists are hopeful these party drugs may help.
Researchers are testing MDMA, known as ecstasy, to treat depression in people who do not respond to current antidepression drugs.
Prosecutors said Shkreli is a "danger to the community" because of alleged threats he made against Clinton and other women online.
Prosecutors say Shkreli is a "danger to the community" because of alleged threats he made against Clinton and other women online.
The company will cut around 620 of its 3,100 full-time employees.
Trump's own opioid commission pushed for a national emergency declaration, USA Today reports.
Janssen Sciences Ireland said Monday it would discontinue further development of the investigational hepatitis C treatment regimen JNJ-4178.
Roche shares tumbled on Monday following news of the failure of trials for its skin cancer treatment Zelboraf.
Allergan transferred patents for its eye drug Restasis to the Saint Regis Mohawk Tribe, which then granted it back an exclusive license.
The motion comes a month after a federal court jury in Brooklyn found the "Pharma bro" guilty of three counts related to securities fraud.
That stunning revelation is contained in a warning letter the FDA sent to the division of drug giant Pfizer, which makes EpiPens for Mylan.
Eli Lilly said on Thursday it would lay off about 8 percent of its employees to focus on developing new medicines and cut costs.
Contact Biotech and Pharma
-
CNBC NEWSLETTERS
Get the best of CNBC in your inbox
Get these newsletters delivered to your inbox, and more info about about our products and service. Privacy Policy.▲Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.
